Tardive dyskinesia: Screening and management
May 1, 2018|Psychiatry
Author and Disclosure Information
Sanjay Gupta, MD, discusses the importance of using the Abnormal Involuntary Movement Scale (AIMS) to screen for tardive dyskinesia, and treating the disorder with vesicular monoamine transporter-2 (VMAT-2) inhibitors.